173 results on '"Xia, Mingfeng"'
Search Results
2. Jatrorrhizine inhibits Piezo1 activation and reduces vascular inflammation in endothelial cells
3. Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
4. Association of vitamin D deficiency and subclinical diabetic peripheral neuropathy in type 2 diabetes patients
5. Characteristics of changes in plasma proteome profiling after sleeve gastrectomy
6. The causal associations of circulating amino acids with blood pressure: a Mendelian randomization study
7. DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing
8. Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients
9. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
10. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
11. Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism
12. DNA methylation age acceleration contributes to the development and prediction of non-alcoholic fatty liver disease
13. DS21, a new noninvasive technology, is effective and safe for screening for prediabetes and diabetes in Chinese population
14. Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2
15. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c
16. Highly Efficient Flame-Retardant and Enhanced PVA-Based Composite Aerogels through Interpenetrating Cross-Linking Networks
17. Updates of precision medicine in type 2 diabetes
18. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans
19. Twelve Loci Associated With Bone Density in Middle-aged and Elderly Chinese: The Shanghai Changfeng Study
20. Piezo1 in vascular remodeling of atherosclerosis and pulmonary arterial hypertension: A potential therapeutic target
21. LC–MS-based lipidomic analysis of liver tissue sample from spontaneously hypertensive rats treated with extract hawthorn fruits
22. Nanocellulose-Based Composite Materials Used in Drug Delivery Systems
23. Myeloid Piezo1 Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation
24. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
25. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression
26. Editorial: opposite effects of genetic polymorphisms known to induce NAFLD on hepatic and cardiovascular outcomes in Chinese population—authors' reply
27. Inhibition of chemically and mechanically activated Piezo1 channels as a mechanism for ameliorating atherosclerosis with salvianolic acid B
28. Cover Image
29. Additional file 2 of The causal associations of circulating amino acids with blood pressure: a Mendelian randomization study
30. Additional file 3 of The causal associations of circulating amino acids with blood pressure: a Mendelian randomization study
31. NAFLD‐related gene polymorphisms and all‐cause and cause‐specific mortality in an Asian population: the Shanghai Changfeng Study
32. Update on genetics and epigenetics in metabolic associated fatty liver disease
33. Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics
34. Type 2 Diabetes Is Causally Associated With Reduced Serum Osteocalcin: A Genomewide Association and Mendelian Randomization Study
35. Liver fat content is independently associated with microalbuminuria in a normotensive, euglycaemic Chinese population: a community-based, cross-sectional study
36. Myeloid Deletion Protects Renal Fibrosis by Restraining Macrophage Infiltration and Activation.
37. Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
38. Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver
39. Osteocalcin and Non‐Alcoholic Fatty Liver Disease: Lessons From Two Population‐Based Cohorts and Animal Models
40. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation
41. Fasting Serum Fructose Levels Are Associated With Risk of Incident Type 2 Diabetes in Middle-Aged and Older Chinese Population
42. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans
43. Regional difference in the susceptibility of non-alcoholic fatty liver disease in China
44. Osteocalcin and Non‐Alcoholic Fatty Liver Disease: Lessons From Two Population‐Based Cohorts and Animal Models.
45. The Microstructure of GNR and the Mechanical Properties of Biobased PLA/GNR Thermoplastic Vulcanizates with Excellent Toughness
46. Optimal Vitamin D Status in a Middle-Aged and Elderly Population Residing in Shanghai, China
47. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21
48. Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: The Shanghai Changfeng Study
49. Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population
50. Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.